.
The clinical trial showed that quarter-dose-sized shots were as effective for kids under 6 as regular-sized shots were for adults.
The drugmaker will make its formal request after a clinical trial showed its vaccine worked effectively in babies, toddlers and preschoolers, citing three sources with knowledge.